Synopsis
Synopsis
0
NDC API
0
VMF
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Debridat
2. Maleate Salt, Trimebutine
3. Maleate, Trimebutine
4. Modulon
5. Polibutin
6. Salt, Trimebutine Maleate
7. Tm 906
8. Tm-906
9. Tm906
10. Transacalm
11. Trimebutine
12. Trimebutine Maleate Salt
1. 34140-59-5
2. Debridat
3. Polibutin
4. Trimebutine Maleate Salt
5. Trimebutine (maleate)
6. Trimebutine Maleate [jan]
7. Dkm38hxx5a
8. H4xzj9gx7t
9. 2-(dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate Maleate
10. Trimebutine Maleate, (+)-
11. Trimebutine Maleate, (-)-
12. Smr000058893
13. Mls000028659
14. 2a051gm4ym
15. 3,4,5-trimethoxybenzoic Acid 2-(dimethylamino)-2-phenylbutyl Ester Maleate Salt
16. Nsc-758900
17. 58997-92-5
18. Ncgc00096059-01
19. Dsstox_cid_26017
20. Dsstox_rid_81292
21. Dsstox_gsid_46017
22. 58997-91-4
23. Cerekinon
24. Dromostat
25. Trimedat
26. Ibutin
27. Mls001401430
28. Digerent Polifarma
29. (z)-but-2-enedioic Acid;[2-(dimethylamino)-2-phenylbutyl] 3,4,5-trimethoxybenzoate
30. Smr000653473
31. Cas-34140-59-5
32. Smr000471622
33. Tm 906
34. Unii-2a051gm4ym
35. Trimebutinemaleate
36. Cerekinon (tn)
37. Einecs 251-845-9
38. Einecs 261-549-1
39. Einecs 261-550-7
40. Opera_id_1549
41. Unii-dkm38hxx5a
42. Unii-h4xzj9gx7t
43. Schembl67225
44. Trimebutine Maleate (jp17)
45. Mls001076527
46. Mls001333691
47. Spectrum1505011
48. Chembl1325297
49. Dtxsid5046017
50. Trimebutine Maleate [mi]
51. Chebi:32261
52. Hy-b0380a
53. Trimebutine For System Suitability
54. Hms2051k18
55. Hms2231d14
56. Hms2232k06
57. Hms2236j08
58. Hms3886o08
59. Pharmakon1600-01505011
60. Trimebutine Maleate [mart.]
61. Tox21_111554
62. 2-(dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate, Maleate
63. Mfcd00133874
64. Nsc758900
65. S5507
66. Trimebutine Maleate [who-dd]
67. (-)-2-(dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate, Maleate
68. Akos015963753
69. Tox21_111554_1
70. Ccg-100892
71. Ccg-213940
72. Cs-4235
73. Ks-1316
74. Nc00142
75. Nsc 758900
76. Ncgc00018269-05
77. Ac-18005
78. Trimebutine Maleate [ep Monograph]
79. Trimebutine Maleate Salt, Analytical Standard
80. D01500
81. A822092
82. Sr-01000003154
83. Q-201885
84. Sr-01000003154-5
85. Q27254453
86. Trimebutine Maleate, European Pharmacopoeia (ep) Reference Standard
87. 2-dimethylamino-2-phenylbutyl 3,4,5-trimethoxybenzoate Hydrogen Maleate
88. (1-ethyl-1-phenyl-2-(3,4,5-trimethoxybenzoyloxy)ethyl)dimethylammonium Hydrogen Maleate
89. Benzoic Acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-phenylbutyl Ester, (+)-, (2z)-2-butenedioate
90. Benzoic Acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-phenylbutyl Ester, (+)-, (z)-2-butenedioate
91. Benzoic Acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-phenylbutyl Ester, (-)-, (2z)-2-butenedioate
92. Benzoic Acid, 3,4,5-trimethoxy-, 2-(dimethylamino)-2-phenylbutyl Ester, (-)-, (z)-2-butenedioate
93. Benzoic Acid, 3,4,5-trimethoxy-, Beta-(dimethylamino)-beta-ethylphenethyl Ester, Maleate (1:1)
| Molecular Weight | 503.5 g/mol |
|---|---|
| Molecular Formula | C26H33NO9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 12 |
| Exact Mass | 503.21553163 g/mol |
| Monoisotopic Mass | 503.21553163 g/mol |
| Topological Polar Surface Area | 132 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 585 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
53
PharmaCompass offers a list of Trimebutine Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trimebutine Maleate manufacturer or Trimebutine Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trimebutine Maleate manufacturer or Trimebutine Maleate supplier.
PharmaCompass also assists you with knowing the Trimebutine Maleate API Price utilized in the formulation of products. Trimebutine Maleate API Price is not always fixed or binding as the Trimebutine Maleate Price is obtained through a variety of data sources. The Trimebutine Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Trimedat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimedat, including repackagers and relabelers. The FDA regulates Trimedat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimedat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trimedat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trimedat supplier is an individual or a company that provides Trimedat active pharmaceutical ingredient (API) or Trimedat finished formulations upon request. The Trimedat suppliers may include Trimedat API manufacturers, exporters, distributors and traders.
click here to find a list of Trimedat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trimedat DMF (Drug Master File) is a document detailing the whole manufacturing process of Trimedat active pharmaceutical ingredient (API) in detail. Different forms of Trimedat DMFs exist exist since differing nations have different regulations, such as Trimedat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trimedat DMF submitted to regulatory agencies in the US is known as a USDMF. Trimedat USDMF includes data on Trimedat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trimedat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trimedat suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trimedat Drug Master File in Japan (Trimedat JDMF) empowers Trimedat API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trimedat JDMF during the approval evaluation for pharmaceutical products. At the time of Trimedat JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trimedat suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Trimedat Drug Master File in Korea (Trimedat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Trimedat. The MFDS reviews the Trimedat KDMF as part of the drug registration process and uses the information provided in the Trimedat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Trimedat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Trimedat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Trimedat suppliers with KDMF on PharmaCompass.
A Trimedat CEP of the European Pharmacopoeia monograph is often referred to as a Trimedat Certificate of Suitability (COS). The purpose of a Trimedat CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Trimedat EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Trimedat to their clients by showing that a Trimedat CEP has been issued for it. The manufacturer submits a Trimedat CEP (COS) as part of the market authorization procedure, and it takes on the role of a Trimedat CEP holder for the record. Additionally, the data presented in the Trimedat CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Trimedat DMF.
A Trimedat CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Trimedat CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Trimedat suppliers with CEP (COS) on PharmaCompass.
A Trimedat written confirmation (Trimedat WC) is an official document issued by a regulatory agency to a Trimedat manufacturer, verifying that the manufacturing facility of a Trimedat active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trimedat APIs or Trimedat finished pharmaceutical products to another nation, regulatory agencies frequently require a Trimedat WC (written confirmation) as part of the regulatory process.
click here to find a list of Trimedat suppliers with Written Confirmation (WC) on PharmaCompass.
Trimedat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trimedat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trimedat GMP manufacturer or Trimedat GMP API supplier for your needs.
A Trimedat CoA (Certificate of Analysis) is a formal document that attests to Trimedat's compliance with Trimedat specifications and serves as a tool for batch-level quality control.
Trimedat CoA mostly includes findings from lab analyses of a specific batch. For each Trimedat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trimedat may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimedat EP), Trimedat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimedat USP).